F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works
The Food and Drug Administration on Monday approved the first new medication for Alzheimer’s disease in nearly two decades, a contentious decision made despite opposition from the agency’s independent advisory committee and some Alzheimer’s experts who said there was not enough evidence that the drug can help patients. The drug, aducanumab, which will go by…
Details